Technical innovations in peritoneal dialysis (PD), now used widely for the long-term
treatment of ESRD, have significantly reduced therapy-related complications, allowing …

The development of peritoneal dialysis (PD) as a successful therapy has and still depends
on experimental models to test and understand critical pieces of pathophysiology. To date …

Background Variability in ultrafiltration influences prescriptions and outcomes in patients
with kidney failure who are treated with peritoneal dialysis. Variants in AQP1, the gene that …

Lay summary Peritoneal dialysis (PD) uses the peritoneal membrane for dialysis. The
peritoneal membrane is a thin layer of tissue that lines the abdomen. The lining is used as a …

Long-term peritoneal dialysis can lead to morphological and functional changes in the
peritoneum. Although the range of morphological alterations is known for the peritoneal …

The effect of peritoneal dialysates with low–glucose degradation products on peritoneal
membrane morphology is largely unknown, with functional relevancy predominantly derived …

Encapsulating peritoneal sclerosis (EPS) is a rare but severe complication of peritoneal
dialysis (PD) characterized by extensive fibrosis of the peritoneum. Changes in peritoneal …

Automated methods for delivering peritoneal dialysis (PD) to persons with end-stage renal
disease continue to gain popularity worldwide, particularly in developed countries. However …

Ultrafiltration is essential in peritoneal dialysis (PD) for maintenance of euvolemia, making
ultrafiltration insufficiency—preferably called ultrafiltration failure—an important …

A healthy and functional peritoneal membrane is key to achieving sufficient ultrafiltration and
restoring fluid balance, a major component of high-quality prescription in patients treated …